Global Brucellosis Vaccines Market Size

Brucellosis Vaccines Market Analysis

The brucellosis vaccine market is projected to register a CAGR of 6.2% during the forecast period (2022-2027).

The emergence of the COVID-19 pandemic had an adverse effect on the world economy and the healthcare system. The lockdown all over the globe has affected the supply chain of pharmaceuticals, medical devices, and biotechnological products both for humans and animals. For instance, according to the July 2021 report titled 'Impact of COVID-19 on the delivery of veterinary services and animal disease reporting: (May-June 2020/June-August 2020)', the participants in both polls stated that COVID-19-related movement restrictions had been established in their home countries and had a detrimental effect on the operations of the veterinary services and in the first poll, 93% of respondents said COVID-19 had a negative impact on their veterinary services, and 70% said it was harder for field agents to carry out surveillance operations and field investigations. Hence, COVID-19 is expected to have a significant impact on the studied market, however, with the declining cases of COVID-19 and the opening of the world economy, the brucellosis vaccine market is expected to regain its full potential over the forecast period.

Brucellosis is one of the most widespread zoonoses transmitted by animals, and in endemic areas, human brucellosis has serious public health consequences. Expansion of animal industries and urbanization, and the lack of hygienic measures in animal husbandry and food handling, partly account for brucellosis remaining a public health hazard. For instance, according to an article published in November 2021, titled 'Brucellosis: Epidemiology, Microbiology, Clinical Manifestations, and Diagnosis', an estimated 2.4 billion people are thought to be at risk of brucellosis, and there are roughly 500,000 cases reported annually around the world. Also, as per the same source, every age group is impacted and due to rising worldwide travel, trade, and migration, brucellosis is becoming more common thus, the demand for brucellosis vaccines is expected to grow over the forecast period. However, this number is likely underestimated as brucellosis cases are underreported and often misdiagnosed because symptoms are nonspecific, physicians may lack awareness, and laboratory capacity for diagnosis is limited. B. melitensis is the most frequently reported cause of human illness worldwide, while the most widespread potential source of infection is B. abortus. Hence, increasing the prevalence of the disease would increase the demand for a vaccine which would increase the market growth in the upcoming period.

The various initiatives the government and non-government organizations take to raise awareness about animal diseases, health, and protection propel the growth of the studied market over the forecast period. The government of different nations is introducing plans and guidelines for animal welfare. For Instance, in May 2021, United Kingdom Government introduced the first-ever action plan to improve the welfare and conservation of animals at home and abroad. The action plans include improvement and welfare programs for all animals, like incentivizing farmers to improve animal health and welfare through future farming policy. Such initiatives raise awareness about animal health and thus boost the market's growth. Furthermore, in Australia, the Animal Welfare Task Group developed animal welfare standards and guidelines for cattle and sheep. The national livestock identification system (NLIS), an electronic identification system in which each animal is tagged with a radiofrequency identification device, has been developed for cattle. Also, in September 2020, the international animal welfare organization World Animal Protection, along with National Disaster Response Force (NDRF) and other organizations and local communities, organized mobile veterinary treatment camps for animals affected by the floods in Assam. Thus, the studied market is expected to project growth over the forecast period due to the abovementioned factors. However, stringent regulation for animal vaccines is likely to hinder the market growth.